Oric Pharmaceuticals (ORIC)

• Market cap: $1.35B
• 1 day: 5.62%
• 5 days: -1.91%
• 1 month: 29.79%
• 3 months: 26.59%
• 6 months: 175.79%
• Year to date: 68.28%
• 1 year: 46.01%
• 5 years: -40.47%
• 10 years: -46.06%
• Sector: Healthcare
• Industry: Biotechnology

About: ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Employees: 128